Skip to main content
Premium Trial:

Request an Annual Quote

Enigma Diagnostics Exclusively Licenses UK Defense Lab IP Supporting RT-PCR Systems

NEW YORK (GenomeWeb News) — Enigma Diagnostics yesterday said it has licensed a “broad range” of technologies from the UK’s Defense Science and Technology Laboratory that will give the company “much greater control” over IP “at the heart” of its real-time PCR systems.
The worldwide exclusive license covers 25 DSTL patents and patent applications. In particular, the license covers the Pyrostart, ResonSense, and Temperature Control, technologies, which Enigma called “important elements” of its RT-PCR systems.
These systems are being developed to rapidly detect and identify pathogens, including bacteria and viruses, in clinical, environmental, and biological samples, Enigma said.
The deal follows an initial license agreement that Enigma signed in 2004 with the group, which is a center of scientific excellence for the UK Ministry of Defense.
The new agreement, which will remain in place until 2026, enables Enigma to sub-license any of the technologies for PCR and non-PCR applications to potential partners and collaborators.
Enigma, which will obtain an undisclosed number of trademarks linked to the IP, will be able to patent improvements that it makes to any of the technologies.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.